MASLD in people with HIV exhibits higher fibrosis stage despite lower disease activity than in matched controls.
Allende DS, Cummings O, Sternberg AL, Behling CA, Carpenter D, Gill RM, Guy CD, Yeh MM, Gawrieh S, Sterling RK, Naggie S, Loomba R, Price JC, McLaughlin M, Hadigan C, Crandall H, Belt P, Wilson L, Chalasani NP, Kleiner DE; HIV NASH and NASH Clinical Research Groups.
Allende DS, et al. Among authors: belt p.
Aliment Pharmacol Ther. 2024 Nov;60(10):1351-1360. doi: 10.1111/apt.18236. Epub 2024 Sep 5.
Aliment Pharmacol Ther. 2024.
PMID: 39238213